Roundview Capital LLC Pfizer Inc Transaction History

Roundview Capital LLC

$1.25 Billion
Q2 2024

A detailed history of Roundview Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Roundview Capital LLC holds 42,741 shares of PFE stock, worth $1.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

42,741

Previous 46,858 8.79%

Holding current value

$1.2 Million

Previous $1.3 Million 8.08%

% of portfolio

0.1%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $103,995 - $121,863	-4,117 Reduced 8.79%	42,741 $1.2 Million
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $97,398 - $111,844	-3,762 Reduced 7.43%	46,858 $1.3 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $276,377 - $358,983	-10,577 Reduced 17.28%	50,620 $1.46 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $74,256 - $86,798	-2,314 Reduced 3.64%	61,197 $2.03 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $18,060 - $20,895	500 Added 0.79%	63,511 $2.33 Million
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $132,468 - $172,454	-3,363 Reduced 5.07%	63,011 $2.57 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $100,868 - $131,672	2,416 Added 3.78%	66,374 $3.4 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $8,051 - $9,829	-184 Reduced 0.29%	63,958 $2.8 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $27,359 - $32,439	-588 Reduced 0.91%	64,142 $3.36 Million
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $44,377 - $54,989	970 Added 1.52%	64,730 $3.35 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $120,613 - $178,788	-2,919 Reduced 4.38%	63,760 $3.77 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $495,609 - $636,653	12,627 Added 23.36%	66,679 $2.87 Million
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $296,293 - $335,650	-8,251 Reduced 13.24%	54,052 $2.12 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $89,987 - $101,487	-2,687 Reduced 4.13%	62,303 $2.26 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $62,321 - $79,246	-1,862 Reduced 2.79%	64,990 $2.39 Million
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $4,667 - $5,475	-147 Reduced 0.22%	66,852 $2.45 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $161,021 - $195,342	-5,346 Reduced 7.39%	66,999 $2.19 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $231,187 - $330,316	-8,553 Reduced 10.57%	72,345 $2.36 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $118,775 - $134,794	-3,608 Reduced 4.27%	80,898 $3.17 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $189,514 - $245,744	5,833 Added 7.41%	84,506 $3.04 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $55,802 - $62,653	-1,509 Reduced 1.88%	78,673 $3.41 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $254,700 - $279,830	6,792 Added 9.25%	80,182 $3.41 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $217,201 - $247,633	5,646 Added 8.33%	73,390 $3.2 Million
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $421,464 - $511,210	12,227 Added 22.02%	67,744 $2.99 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $1,780 - $1,898	54 Added 0.1%	55,517 $2.01 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $199,277 - $231,189	-6,245 Reduced 10.12%	55,463 $1.97 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $7,017 - $7,446	211 Added 0.34%	61,708 $2.24 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $130,851 - $144,147	-4,221 Reduced 6.42%	61,497 $2.2 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $2.04 Million - $2.24 Million	65,718	65,718 $2.21 Million

Others Institutions Holding PFE

# of Institutions

3,240

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $158B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roundview Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roundview Capital LLC with notifications on news.

Account

Roundview Capital LLC Pfizer Inc Transaction History